Your browser doesn't support javascript.
loading
Design, Synthesis, and Evaluation of Inhibitors of Hedgehog Acyltransferase.
Ritzefeld, Markus; Zhang, Leran; Xiao, Zhangping; Andrei, Sebastian A; Boyd, Olivia; Masumoto, Naoko; Rodgers, Ursula R; Artelsmair, Markus; Sefer, Lea; Hayes, Angela; Gavriil, Efthymios-Spyridon; Raynaud, Florence I; Burke, Rosemary; Blagg, Julian; Rzepa, Henry S; Siebold, Christian; Magee, Anthony I; Lanyon-Hogg, Thomas; Tate, Edward W.
Afiliação
  • Ritzefeld M; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Zhang L; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Xiao Z; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Andrei SA; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Boyd O; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Masumoto N; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Rodgers UR; National Heart and Lung Institute, Imperial College London, London SW7 2AZ, U.K.
  • Artelsmair M; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Sefer L; Division of Structural Biology, University of Oxford, Oxford OX3 7BN, U.K.
  • Hayes A; Division of Cancer Therapeutics, Centre for Cancer Drug Discovery, Institute of Cancer Research, London SM2 5NG, U.K.
  • Gavriil ES; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Raynaud FI; Division of Cancer Therapeutics, Centre for Cancer Drug Discovery, Institute of Cancer Research, London SM2 5NG, U.K.
  • Burke R; Division of Cancer Therapeutics, Centre for Cancer Drug Discovery, Institute of Cancer Research, London SM2 5NG, U.K.
  • Blagg J; Division of Cancer Therapeutics, Centre for Cancer Drug Discovery, Institute of Cancer Research, London SM2 5NG, U.K.
  • Rzepa HS; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Siebold C; Division of Structural Biology, University of Oxford, Oxford OX3 7BN, U.K.
  • Magee AI; National Heart and Lung Institute, Imperial College London, London SW7 2AZ, U.K.
  • Lanyon-Hogg T; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
  • Tate EW; Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
J Med Chem ; 67(2): 1061-1078, 2024 Jan 25.
Article em En | MEDLINE | ID: mdl-38198226
ABSTRACT
Hedgehog signaling is involved in embryonic development and cancer growth. Functional activity of secreted Hedgehog signaling proteins is dependent on N-terminal palmitoylation, making the palmitoyl transferase Hedgehog acyltransferase (HHAT), a potential drug target and a series of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines have been identified as HHAT inhibitors. Based on structural data, we designed and synthesized 37 new analogues which we profiled alongside 13 previously reported analogues in enzymatic and cellular assays. Our results show that a central amide linkage, a secondary amine, and (R)-configuration at the 4-position of the core are three key factors for inhibitory potency. Several potent analogues with low- or sub-µM IC50 against purified HHAT also inhibit Sonic Hedgehog (SHH) palmitoylation in cells and suppress the SHH signaling pathway. This work identifies IMP-1575 as the most potent cell-active chemical probe for HHAT function, alongside an inactive control enantiomer, providing tool compounds for validation of HHAT as a target in cellular assays.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Hedgehog Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Hedgehog Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article